MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 138 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $38,000 | -62.7% | 30,392 | -8.1% | 0.00% | -100.0% |
| Q1 2017 | $102,000 | -29.2% | 33,075 | -6.0% | 0.00% | 0.0% |
| Q4 2016 | $144,000 | -38.7% | 35,175 | -4.8% | 0.00% | -50.0% |
| Q3 2016 | $235,000 | +30.6% | 36,931 | +10.5% | 0.00% | 0.0% |
| Q2 2016 | $180,000 | -40.0% | 33,431 | -6.8% | 0.00% | -33.3% |
| Q1 2016 | $300,000 | +7.9% | 35,881 | +1.9% | 0.00% | 0.0% |
| Q4 2015 | $278,000 | -5.4% | 35,216 | +2.0% | 0.00% | 0.0% |
| Q3 2015 | $294,000 | -13.8% | 34,515 | +25.2% | 0.00% | 0.0% |
| Q2 2015 | $341,000 | +76.7% | 27,565 | +69.9% | 0.00% | +50.0% |
| Q1 2015 | $193,000 | – | 16,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,211,880 | $17,474,000 | 4.63% |
| Parametrica Management Ltd | 21,228 | $168,000 | 1.11% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $653,000 | 0.73% |
| Virtus ETF Advisers LLC | 33,570 | $265,000 | 0.73% |
| Opus Point Partners Management, LLC | 122,500 | $968,000 | 0.64% |
| NEXTHERA CAPITAL LP | 36,000 | $284,000 | 0.40% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 7,255,815 | $57,321,000 | 0.39% |
| Cannell & Co. | 1,051,178 | $7,751,000 | 0.25% |
| Tekla Capital Management LLC | 853,787 | $6,745,000 | 0.24% |
| STONERIDGE INVESTMENT PARTNERS LLC | 208,282 | $1,645,000 | 0.22% |